Navigation Links
Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
Date:2/23/2011

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ -- Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, will be relocating its West Coast office from San Francisco to San Diego.  Thomas, McNerney partner Pratik Shah, Ph.D. announced the move at BIOCOM's first global partnering conference being held in San Diego.

"Southern California is home to many top-tier scientific and medical centers; it's long been a fertile breeding ground for successful medical technology companies, and it's populated by some of the smartest, most capable people in the country," Dr. Shah said.  "It has all the ingredients that make it an ideal home for Thomas, McNerney's West Coast office." Thomas, McNerney & Partners has ten investments on the West Coast, six of which are in Southern California.

In addition, well known San Diego biopharmaceutical executive Larry Fritz, Ph.D. has joined Thomas, McNerney as an Entrepreneur in Residence and will be based out of the firm's new West Coast office.  Dr. Fritz has founded or co-founded a string of successful biotechnology companies including Athena Neurosciences, Idun, Conforma, Cabrellis and Covella.  He will assist Thomas, McNerney in selecting investments and building companies.  

"Larry has had a long and distinguished career in founding and managing biotechnology companies," said Dr. Shah.  "Importantly, he has been especially successful in creating value for investors and engineering profitable exits in multiple private companies.  Strategically, operationally and scientifically, he is a good fit for the way we do business at Thomas, McNerney, and he will be a great addition to our team."

About Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management, focused on investing in life science and medical technology companies at all stages of development.  In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization.  Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies, as well as recapitalizations.  The firm has offices in Connecticut, Minnesota and California. For further information, please visit www.tm-partners.com.


'/>"/>
SOURCE Thomas, McNerney & Partners, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference
2. Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
3. Smith & Nephews Exclusive OXINIUM™ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market
4. Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem
5. Reportlinker Adds U.S. Pain Management Products & Services: a Market Analysis - 7th Edition
6. AT&T Connected Vitality GlowCaps Wins 2011 Global Mobile Award
7. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
8. NeoStem to Present at 13th Annual BIO CEO & Investor Conference
9. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
10. Sutter Health Among the Nations Top Employers According to Readers of CAREERS & the disABLED Magazine
11. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/4/2017)... to the Centers for Disease Control and Prevention (CDC), influenza vaccination ... is helping communities across Massachusetts , Connecticut ... flu shots through the end of the month. *Some exclusions ... ... shot is by the end of October, according to the Centers for ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain ... inventor from Austin, Texas, has identified a solution. , She developed a prototype for ... lighting. As such, it eliminates the need to turn on a light when taking ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
Breaking Medicine News(10 mins):